Short-course radiation after breast reconstruction
Part of Cancer, Skin clinical trials.
This study tests a shorter course of radiation therapy after breast reconstruction surgery for people with breast cancer. It aims to see if fewer, larger doses of radiation are safe and effective after mastectomy with reconstruction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You are generally well enough to take care of yourself (Karnofsky score of 60 or above).
- You have been diagnosed with invasive breast cancer (confirmed by biopsy).
- You had your entire breast removed and had reconstruction or a tissue expander placed, with clear margins (no cancer left behind).
- You have completed any recommended chemotherapy before or after surgery.
- Your cancer has not spread to distant organs, and you have not had radiation to the chest before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter course of radiation (fewer, larger doses) with the standard longer course for women who have had breast cancer surgery with implant-based reconstruction. It aims to see if the shorter schedule is just as safe and effective for the chest area, while being more convenient.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
This trial compares standard radiation therapy to a shorter course (hypofractionated) for women who have had a mastectomy with implant reconstruction. The goal is to see if the shorter schedule works as well while possibly reducing side effects for the reconstructed breast.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.